UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.966-971

2013

Volltextzugriff (PDF)

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

The New England journal of medicine, 2016-08, Vol.375 (8), p.754-766

2016

Volltextzugriff (PDF)

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

The lancet oncology, 2016-01, Vol.17 (1), p.27-38

2016

Volltextzugriff (PDF)

Intravascular lymphoma presenting with neurological signs but diagnosed by prostate biopsy: suspicion as a key to early diagnosis

European journal of neurology, 2009-03, Vol.16 (3), p.e39-e41

2009

Volltextzugriff (PDF)

Intravascular lymphomatosis of the nervous system

Journal of neurology, 2008-10, Vol.255 (10), p.1590-1592

2008

Volltextzugriff (PDF)

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Clinical lymphoma, myeloma and leukemia, 2018-10, Vol.18 (10), p.e401-e419

2018

Volltextzugriff (PDF)

CHRONOS‐3: RANDOMIZED PHASE III STUDY OF COPANLISIB PLUS RITUXIMAB VS RITUXIMAB/PLACEBO IN RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (INHL)

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Surgery for Type B Ankle Fracture Treatment: a Combined Randomised and Observational Study (CROSSBAT)

BMJ open, 2017-03, Vol.7 (3), p.e013298-e013298

2017

Volltextzugriff (PDF)

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1028-1029

2022

Volltextzugriff (PDF)

O57 Autologous hematopoietic stem cell transplantation in T/0-cell non Hodgkin lymphoma. Single center experiences

Blood reviews, 2007, Vol.21, p.S84-S85

2007

Volltextzugriff (PDF)

P060 Molecular genetic results of Transdanubian haemophilic patients

Blood reviews, 2007, Vol.21, p.S105-S105

2007

Volltextzugriff (PDF)

Hepatitis C virus infection associated with B-cell non-Hodgkin's lymphoma in Hungarian patients

British journal of haematology, 2000-08, Vol.110 (2), p.497-498

2000

Volltextzugriff (PDF)

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation

Annals of hematology, 1997-11, Vol.75 (5-6), p.239-241

1997

Volltextzugriff (PDF)

826O Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial

Annals of oncology, 2021-09, Vol.32, p.S773-S774

2021

Volltextzugriff (PDF)

The existence of lymphoid lineage restricted philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement

Leukemia, 2000-06, Vol.14 (6), p.1122-1126

2000

Volltextzugriff (PDF)

P149 Case report: lymphomatoid granulomatosis transformed from CLL

Blood reviews, 2007, Vol.21, p.S134-S134

2007

Volltextzugriff (PDF)

P147 Multiple extranodal relapses in diffuse large B-cell lymphoma (case report)

Blood reviews, 2007, Vol.21, p.S133-S133

2007

Volltextzugriff (PDF)

P171 Influence of favourable and unfavourable genetic prognostic markers and CD 38 expression in chronic lymphocytic leukemia on treatment free interval and overal survival. Single center experience between 2002 2006

Blood reviews, 2007, Vol.21, p.S140-S140

2007

Volltextzugriff (PDF)

P202 Multidrug resistance in chronic lymphocytic leukemia

Blood reviews, 2007, Vol.21, p.S140-S140

2007

Volltextzugriff (PDF)

Changes in adhesion molecule expression and function in B-cell chronic lymphocytic leukaemia after in vitro interferon-α stimulation

European journal of haematology, 1995-01, Vol.54 (1), p.27-33

1995

Volltextzugriff (PDF)

Expression and function of L-selectin molecules (LECAM-1) in B-cell chronic lymphocytic leukemia

Haematologica (Roma), 1994-03, Vol.79 (2), p.132

1994

Volltextzugriff (PDF)

Penile chloroma in a patient with secondary acute myeloid leukemia

European journal of haematology, 2002-05, Vol.68 (5), p.322-322

2002

Volltextzugriff (PDF)

P.1.092 Evaluation of psychiatric side effects ofinterferon-alpha treatment

European neuropsychopharmacology, 2004-10, Vol.14, p.S213-S214

2004

Volltextzugriff (PDF)

Genotypic analysis in primary systemic anaplastic large cell lymphoma

Pathology oncology research, 2003-01, Vol.9 (2), p.104-106

2003

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Intravascular lymphoma presenting with neurological signs but diagnosed by prostate biopsy: suspicion as a key to early diagnosis

Intravascular lymphomatosis of the nervous system

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

CHRONOS‐3: RANDOMIZED PHASE III STUDY OF COPANLISIB PLUS RITUXIMAB VS RITUXIMAB/PLACEBO IN RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (INHL)

Surgery for Type B Ankle Fracture Treatment: a Combined Randomised and Observational Study (CROSSBAT)

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL

O57 Autologous hematopoietic stem cell transplantation in T/0-cell non Hodgkin lymphoma. Single center experiences

P060 Molecular genetic results of Transdanubian haemophilic patients

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

Hepatitis C virus infection associated with B-cell non-Hodgkin's lymphoma in Hungarian patients

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation

826O Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial

The existence of lymphoid lineage restricted philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement

P149 Case report: lymphomatoid granulomatosis transformed from CLL

P147 Multiple extranodal relapses in diffuse large B-cell lymphoma (case report)

P171 Influence of favourable and unfavourable genetic prognostic markers and CD 38 expression in chronic lymphocytic leukemia on treatment free interval and overal survival. Single center experience between 2002 2006

P202 Multidrug resistance in chronic lymphocytic leukemia

Changes in adhesion molecule expression and function in B-cell chronic lymphocytic leukaemia after in vitro interferon-α stimulation

Expression and function of L-selectin molecules (LECAM-1) in B-cell chronic lymphocytic leukemia

Penile chloroma in a patient with secondary acute myeloid leukemia

P.1.092 Evaluation of psychiatric side effects ofinterferon-alpha treatment

Genotypic analysis in primary systemic anaplastic large cell lymphoma

Suchergebnisse filtern